NJ man was hospitalized with Covid-19 month after getting J&J vaccine
A 52-year-old resident of Edison, New Jersey was hospitalized in serious condition and with Covid symptoms, just under 5 weeks after receiving a shot of a vaccine from the manufacturer Johnson & Johnson, reports the NY Post.
"Francisco Cosme was ecstatic when he booked an appointment for the one-dose Johnson & Johnson vaccine at the Javits Center on March 6," the Post wrote.
His daughter said that his father began to suffer from fever, cough and other symptoms on April 1st. He was later taken to hospital, where they tested positive for Covid-19 and placed under 10-day home quarantine.
A week later, Cosme's health deteriorated. The man was experiencing breathing problems. An ambulance arriving at his home diagnosed a lung injury and took him to John F. Kennedy Medical Center.
A week later, Cosme's daughter, Michelle Torres and the rest of the family, including her husband, mother and children, also tested positive for Covid.
According to the official version, Francisco Cosme may have been infected with a non-original strain of the virus, and the vaccine does not protect against variants.
The research results of all vaccines are kept in the strictest confidence. And although the manufacturers say that the vaccine is safe, the same manufacturers hide that the probability of antibodies from Covid-19 does not exceed 80 percent.
A similar incident occurred last week with a woman from Brooklyn. 31-year-old Ashley Allen received one-dose of Johnson & Johnson vaccine on March 30. And although she did not show any symptoms, immediately after the injection she experienced all the side effects of vaccination.
In addition, the US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson's Covid-19 vaccine over six reported US cases of a "rare and severe" type of blood clot. Not only is the J&J vaccine useless, but in six cases it has been fatal.
"CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance," the statement said. "FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot."
As of 4/12, 6.8m+ doses of the J&J vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine. Right now, these adverse events appear to be extremely rare— U.S. FDA (@US_FDA) April 13, 2021